Endocrinology, Vol 125, 1910-1920, Copyright © 1989 by Endocrine Society

ARTICLES

Insulin-like growth factor-binding proteins from vascular endothelial cells: purification, characterization, and intrinsic biological activities

RS Bar, BA Booth, M Boes and BL Dake
Department of Medicine, Veterans Administration Medical Center, Iowa City, Iowa.

Insulin-like growth factor (IGF)-binding proteins are produced by several cell types, including vascular endothelial cells. The production of IGF-binding proteins by endothelial cells is of particular interest, since these cells are directly bathed by the circulating IGFs and form the initial barrier to the passage of circulating IGFs from the bloodstream to subendothelial tissues. We have purified IGF-binding proteins from medium conditioned by cultured bovine endothelial cells by sequential passage over Bio-Gel P-60, multiplication-stimulating activity affinity, anion exchange (DEAE cellulose) and/or hydrophobic (phenyl-Sepharose) chromatography. Two peaks of IGF-binding activity were eluted from the phenyl-Sepharose column. After cross-linking, each peak contained two to five protein bands on gels that specifically bound IGF-I and -II with mol wt ranging from about 28-44K. Material in peak 1 bound IGF-I congruent to IGF-II and had no affinity for insulin and proinsulin. Peak 2 IGF-binding proteins bound IGF-II with substantially higher affinity than IGF-I and did not recognize insulin or proinsulin. Peak 1 material from phenyl- Sepharose chromatography was a potent stimulator of both glucose transport and aminoisobutyric acid (AIB) uptake in microvessel endothelial cells, with maximal stimulation of both processes being 300- 400% of control values. In contrast, peak 2 material either had no intrinsic bioactivity or was slightly inhibitory or stimulatory, depending on the concentration of peak 2 material that was added. The bioactivity in peak 1 was not due to copurification of other endothelial proteins capable of stimulating glucose and AIB uptake, such as IGF-I/-II, platelet-derived growth factor, and basic fibroblast growth factor, since bioactivity was retained after acid treatment, antibody neutralization, and selective affinity chromatography to deplete these other factors. When peak 1 material was added to IGF-I the bioeffects (glucose and AIB uptake) of IGF and binding proteins were additive, and in some experiments the binding proteins potentiated the effect of IGF on endothelial cells, suggesting that the binding protein-IGF complex may retain the bioactivity of both the binding protein(s) and the IGF.

This article has been cited by other articles:

				M. Ivanga, Y. Labrie, E. Calvo, P. Belleau, C. Martel, V. Luu-The, J. Morissette, F. Labrie, and F. Durocher Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus Physiol Genomics, March 14, 2007; 29(1): 13 - 23. [Abstract] [Full Text] [PDF]

				A. W. Wood, P. J. Schlueter, and C. Duan Targeted Knockdown of Insulin-Like Growth Factor Binding Protein-2 Disrupts Cardiovascular Development in Zebrafish Embryos Mol. Endocrinol., April 1, 2005; 19(4): 1024 - 1034. [Abstract] [Full Text] [PDF]

				R. Ramalingam, S. Rafii, S. Worgall, N. R. Hackett, and R. G. Crystal Induction of Endogenous Genes following Infection of Human Endothelial Cells with an E1- E4+ Adenovirus Gene Transfer Vector J. Virol., December 1, 1999; 73(12): 10183 - 10190. [Abstract] [Full Text]

				B. A. Booth, M. Boes, B. L. Dake, and R. S. Bar Isolation and characterization of plasmin-generated bioactive fragments of IGFBP-3 Am J Physiol Endocrinol Metab, March 1, 1999; 276(3): E450 - E454. [Abstract] [Full Text] [PDF]

				D. L. Andress Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E744 - E750. [Abstract] [Full Text] [PDF]

				C. K. Abrass, A. K. Berfield, and D. L. Andress Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration Am J Physiol Renal Physiol, December 1, 1997; 273(6): F899 - F906. [Abstract] [Full Text] [PDF]

				B. L. G. Nyomba, L. Berard, and L. J. Murphy Free Insulin-Like Growth Factor I (IGF-I) in Healthy Subjects: Relationship with IGF-Binding Proteins and Insulin Sensitivity J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2177 - 2181. [Abstract] [Full Text] [PDF]